| Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study MC Garassino, BC Cho, JH Kim, J Mazières, J Vansteenkiste, H Lena, ... The Lancet Oncology 19 (4), 521-536, 2018 | 551 | 2018 |
| Amikacin Liposome Inhalation Suspension for Treatment-Refractory Lung Disease Caused by Mycobacterium avium Complex (CONVERT). A Prospective, Open … DE Griffith, G Eagle, R Thomson, TR Aksamit, N Hasegawa, K Morimoto, ... American journal of respiratory and critical care medicine 198 (12), 1559-1569, 2018 | 272 | 2018 |
| Clade-specific virulence patterns of Mycobacterium tuberculosis complex strains in human primary macrophages and aerogenically infected mice N Reiling, S Homolka, K Walter, J Brandenburg, L Niwinski, M Ernst, ... MBio 4 (4), 10.1128/mbio. 00250-13, 2013 | 161 | 2013 |
| Immunotherapeutic maintenance treatment with toll-like receptor 9 agonist lefitolimod in patients with extensive-stage small-cell lung cancer: results from the exploratory … M Thomas, S Ponce-Aix, A Navarro, J Riera-Knorrenschild, M Schmidt, ... Annals of Oncology 29 (10), 2076-2084, 2018 | 73 | 2018 |
| Lipoarabinomannan-responsive polycytotoxic T cells are associated with protection in human tuberculosis M Busch, C Herzmann, S Kallert, A Zimmermann, C Höfer, D Mayer, ... American journal of respiratory and critical care medicine 194 (3), 345-355, 2016 | 70 | 2016 |
| Therapy and prophylaxis of opportunistic infections in HIV-infected patients: a guideline by the German and Austrian AIDS societies (DAIG/ÖAG)(AWMF 055/066) J Thoden, A Potthoff, JR Bogner, NH Brockmeyer, S Esser, ... Infection 41, 91-115, 2013 | 62 | 2013 |
| Nevirapine Significantly Reduces the Levels of Racemic Methadone and (R)-Methadone in Human Immunodeficiency Virus-Infected Patients H Stocker, G Kruse, P Kreckel, C Herzmann, K Arastéh, J Claus, H Jessen, ... Antimicrobial agents and chemotherapy 48 (11), 4148-4153, 2004 | 56 | 2004 |
| Long-term effect of acetyl-L-carnitine for antiretroviral toxic neuropathy C Herzmann, MA Johnson, M Youle HIV clinical trials 6 (6), 344-350, 2005 | 55 | 2005 |
| Small airway dysfunction links asthma severity with physical activity and symptom control M Abdo, F Trinkmann, AM Kirsten, F Pedersen, C Herzmann, ... The Journal of Allergy and Clinical Immunology: In Practice 9 (9), 3359-3368. e1, 2021 | 54 | 2021 |
| Physical activity, airway resistance and small airway dysfunction in severe asthma T Bahmer, B Waschki, F Schatz, C Herzmann, P Zabel, AM Kirsten, ... European Respiratory Journal 49 (1), 2017 | 53 | 2017 |
| Detection of transrenal DNA for the diagnosis of pulmonary tuberculosis and treatment monitoring I Labugger, J Heyckendorf, S Dees, E Häussinger, C Herzmann, TA Kohl, ... Infection 45, 269-276, 2017 | 41 | 2017 |
| Toll-like receptor 3 blockade in rhinovirus-induced experimental asthma exacerbations: a randomized controlled study PE Silkoff, S Flavin, R Gordon, MJ Loza, PJ Sterk, R Lutter, Z Diamant, ... Journal of Allergy and Clinical Immunology 141 (4), 1220-1230, 2018 | 40 | 2018 |
| Increased frequencies of pulmonary regulatory T-cells in latent Mycobacterium tuberculosis infection C Herzmann, M Ernst, S Ehlers, S Stenger, J Maertzdorf, G Sotgiu, ... European Respiratory Journal 40 (6), 1450-1457, 2012 | 39 | 2012 |
| T2-high asthma phenotypes across lifespan N Maison, J Omony, S Illi, D Thiele, C Skevaki, AM Dittrich, T Bahmer, ... European Respiratory Journal 60 (3), 2022 | 37 | 2022 |
| Efavirenz-induced osteomalacia C Herzmann, K Arastéh Aids 23 (2), 274-275, 2009 | 35 | 2009 |
| Risk for latent and active tuberculosis in Germany C Herzmann, G Sotgiu, O Bellinger, R Diel, S Gerdes, U Goetsch, ... Infection 45, 283-290, 2017 | 33 | 2017 |
| A randomised trial of subcutaneous intermittent Interleukin-2 without antiretroviral therapy in HIV-Infected patients: The UK–Vanguard Study M Youle, S Emery, M Fisher, M Nelson, L Fosdick, G Janossy, C Loveday, ... PLoS clinical trials 1 (1), e3, 2006 | 33 | 2006 |
| Personalized medicine for chronic respiratory infectious diseases: tuberculosis, nontuberculous mycobacterial pulmonary diseases, and chronic pulmonary aspergillosis HJF Salzer, N Wassilew, N Köhler, ID Olaru, G Günther, C Herzmann, ... Respiration 92 (4), 199-214, 2016 | 31 | 2016 |
| Different responses of the oral, nasal and lung microbiomes to cigarette smoke S Pfeiffer, C Herzmann, KI Gaede, D Kovacevic, S Krauss-Etschmann, ... Thorax 77 (2), 191-195, 2022 | 30 | 2022 |
| Discovery and validation of an NMR-based metabolomic profile in urine as TB biomarker JL Izquierdo-Garcia, P Comella-del-Barrio, R Campos-Olivas, ... Scientific reports 10 (1), 22317, 2020 | 30 | 2020 |
